Furthermore, (natural) antibodies against brain amyloid or tau have been observed not only in Alzheimer's disease patients, but also in cognitively healthy elderly individuals [43, 44]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.